Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate

Pharmacotherapies for the treatment of Benign Prostatic Hyperplasia (BPH) are targeted at reducing cellular proliferation (static component) or reducing smooth muscle tone (dynamic component), but response is unpredictable and many patients fail to respond. An impediment to identifying novel pharmac...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Lee, Sophie N., Kraska, Jenna, Papargiris, Melissa, Teng, Linda, Niranjan, Birunthi, Hammar, Johanna, Ryan, Andrew, Frydenberg, Mark, Lawrentschuk, Nathan, Middendorff, Ralf, Ellem, Stuart J., Whittaker, Michael, Risbridger, Gail P., Exintaris, Betty
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7973579/
https://ncbi.nlm.nih.gov/pubmed/33737570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85439-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi